Search company, investor...

Weijing Biomedicine Technology

wigenbio.com

Founded Year

2018

About Weijing Biomedicine Technology

Weijing Biomedicine Technology is a biomedical company. The company develops medicines. The company engages in the research and development of new anti-tumor drugs and technology platforms such as covalent or allosteric small molecules, PROTAC, and drug conjugation. It was founded in 2018 and is based in Shanghai, China.

Headquarters Location

No. 11, Lane 67, Li Bing Road Pilot Free Trade Zone

Shanghai, Shanghai, 201203,

China

Missing: Weijing Biomedicine Technology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Weijing Biomedicine Technology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Weijing Biomedicine Technology Frequently Asked Questions (FAQ)

  • When was Weijing Biomedicine Technology founded?

    Weijing Biomedicine Technology was founded in 2018.

  • Where is Weijing Biomedicine Technology's headquarters?

    Weijing Biomedicine Technology's headquarters is located at No. 11, Lane 67, Li Bing Road, Shanghai.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.